Adma Biologics: Q3 Earnings Snapshot
In this article:
RAMSEY, N.J. (AP) — RAMSEY, N.J. (AP) — Adma Biologics Inc. (ADMA) on Wednesday reported third-quarter net income of $2.6 million, after reporting a loss in the same period a year earlier.
The Ramsey, New Jersey-based company said it had profit of 1 cent per share.
The infectious disease drug developer posted revenue of $67.3 million in the period.
In the final minutes of trading on Wednesday, the company's shares hit $3.62. A year ago, they were trading at $2.61.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ADMA at https://www.zacks.com/ap/ADMA
